Literature DB >> 3093673

Phorbol dibutyrate contractions in rabbit aorta: calcium dependence and sensitivity to nitrovasodilators and 8-BR-cyclic GMP.

E J Sybertz, D M Desiderio, G Tetzloff, P J Chiu.   

Abstract

Phorbol esters activate protein kinase C and induce contraction in vascular smooth muscle. The role of Ca and the sensitivity of this response to nitrovasodilators were evaluated in rabbit aortic rings. Phorbol dibutyrate (PDB) (0.01-10 microM) elicited a concentration-dependent contraction of rabbit aortic rings. Responses to PDB in a salt solution (SS) containing 2.54 mM CaCl2 were not significantly different from those in SS containing 0 Ca and 2 mM ethylene glycol bis(beta-aminoethyl ether)-N,N'-tetraacetic acid. Contractions to PDB (1 microM) in zero Ca SS were not reduced by depletion of the norepinephrine-sensitive pool of intracellular Ca. The Ca entry blockers verapamil (100 microM) and nifedipine (100 microM) did not affect PDB (1 microM) responses. Nitroprusside (0.1-10 microM) and nitroglycerin (0.1-10 microM) inhibited PDB contractions in both normal SS and Ca-free SS. 8-Br-cyclic GMP (100 microM) also inhibited PDB responses. Effects of PDB on 45Ca fluxes were evaluated in separate experiments. PDB (1 and 10 microM) elicited contraction, but no change in 45Ca uptake or efflux. In contrast KCl (80 mM) and norepinephrine (10 microM) elicited an increase in both influx and efflux, reflecting a rise in cytosolic Ca. The data suggest that PDB-induced contractions in rabbit aorta are independent of extracellular Ca and are not associated with a rise in cytosolic Ca as detected by calcium flux studies.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093673

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  Protein kinase C-mediated contractile responses of arteries from diabetic rats.

Authors:  W Abebe; K M MacLeod
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

2.  Interaction of phorbol esters with Ca2+ channels in smooth muscle.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1987-06       Impact factor: 8.739

3.  Ca2+-dependent actin remodeling in the contracting A7r5 cell.

Authors:  C Li; M E Fultz; J Parkash; W B Rhoten; G L Wright
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

4.  Membrane-associated signal transduction modulates contractile responses to Ca2+ in saponin-skinned coronary smooth muscle.

Authors:  R Fermum; D Kosche; K U Möritz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

5.  Tissue selectivity and spasmogen selectivity of relaxant drugs in airway and pulmonary vascular smooth muscle contracted by PGF2 alpha or endothelin.

Authors:  S R O'Donnell; J C Wanstall; C S Kay; X P Zeng
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

Review 6.  Signal transduction in cavernous smooth muscle.

Authors:  C G Stief; T Noack; K E Andersson
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  Impairment of relaxations to acetylcholine and nitric oxide by a phorbol ester in rat isolated aorta.

Authors:  K J Morrison; D Pollock
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

8.  Phorbol 12,13-dibutyrate increases vascular tone but has a dual action on intracellular calcium levels in porcine coronary arteries.

Authors:  T Mori; T Yanagisawa; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

9.  Phorbol 12,13-dibutyrate, an activator of protein kinase C, stimulates both contraction and Ca2+ fluxes in dog saphenous vein.

Authors:  P J Chiu; G Tetzloff; M Chatterjee; E J Sybertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-08       Impact factor: 3.000

10.  Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution.

Authors:  S Duty; A H Weston
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.